Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hannah

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Molecular Genetics and Metabolism Reports|March 4, 2022
Very early-onset inflammatory bowel disease: Novel description in glycogen storage disease type IaWilliam B Hannah, Ricardo C Ong, Margarita Nieto Moreno, et al.
Journal of Clinical Microbiology|July 24, 2009
Strain typing and antimicrobial resistance of fluoroquinolone-resistant Neisseria gonorrhoeae causing a California infection outbreakSheldon R Morris, Douglas F Moore, Paul B Hannah, et al.
Molecular Genetics & Genomic Medicine|August 3, 2019
The expanding phenotype of OFD1-related disorders: Hemizygous loss-of-function variants in three patients with primary ciliary dyskinesiaWilliam B Hannah, Suzanne DeBrosse, BreAnna Kinghorn, et al.
Scientific Reports|October 10, 2019
Hemophilia A and B mice, but not VWF<sup>-/-</sup>mice, display bone defects in congenital development and remodeling after injurySarah Taves, Junjiang Sun, Eric W Livingston, et al.
Molecular Genetics and Metabolism Reports|December 18, 2019
Life-threatening presentations of propionic acidemia due to the Amish <i>PCCB</i> founder variantWilliam B Hannah, Katherine J Dempsey, Lori-Anne P Schillaci, et al.
The Journal of Pediatrics|October 16, 2019
Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Variants in Individuals Evaluated for Primary Ciliary DyskinesiaWilliam B Hannah, Rebecca Truty, Virginia Gonzales, et al.
Plos One|October 12, 2018
Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis populationDeepika Polineni, Annalisa V Piccorelli, William B Hannah, et al.
American Journal of Medical Genetics. Part A|August 16, 2022
Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegalyWilliam B Hannah, Katherine Ryan, Surekha Pendyal, et al.
Human Gene Therapy|November 25, 2014
Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trialPaul E Monahan, Junjiang Sun, Tong Gui, et al.
JAMA|September 10, 2009
Genetic modifiers of liver disease in cystic fibrosisJaclyn R Bartlett, Kenneth J Friedman, Simon C Ling, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Molecular Genetics and Metabolism Reports|March 4, 2022
Very early-onset inflammatory bowel disease: Novel description in glycogen storage disease type IaWilliam B Hannah, Ricardo C Ong, Margarita Nieto Moreno, et al.
Journal of Clinical Microbiology|July 24, 2009
Strain typing and antimicrobial resistance of fluoroquinolone-resistant Neisseria gonorrhoeae causing a California infection outbreakSheldon R Morris, Douglas F Moore, Paul B Hannah, et al.
Molecular Genetics & Genomic Medicine|August 3, 2019
The expanding phenotype of OFD1-related disorders: Hemizygous loss-of-function variants in three patients with primary ciliary dyskinesiaWilliam B Hannah, Suzanne DeBrosse, BreAnna Kinghorn, et al.
Scientific Reports|October 10, 2019
Hemophilia A and B mice, but not VWF<sup>-/-</sup>mice, display bone defects in congenital development and remodeling after injurySarah Taves, Junjiang Sun, Eric W Livingston, et al.
Molecular Genetics and Metabolism Reports|December 18, 2019
Life-threatening presentations of propionic acidemia due to the Amish <i>PCCB</i> founder variantWilliam B Hannah, Katherine J Dempsey, Lori-Anne P Schillaci, et al.
The Journal of Pediatrics|October 16, 2019
Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Variants in Individuals Evaluated for Primary Ciliary DyskinesiaWilliam B Hannah, Rebecca Truty, Virginia Gonzales, et al.
Plos One|October 12, 2018
Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis populationDeepika Polineni, Annalisa V Piccorelli, William B Hannah, et al.
American Journal of Medical Genetics. Part A|August 16, 2022
Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegalyWilliam B Hannah, Katherine Ryan, Surekha Pendyal, et al.
Human Gene Therapy|November 25, 2014
Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trialPaul E Monahan, Junjiang Sun, Tong Gui, et al.
JAMA|September 10, 2009
Genetic modifiers of liver disease in cystic fibrosisJaclyn R Bartlett, Kenneth J Friedman, Simon C Ling, et al.
Pageof 3